Icon

Odefsey - (200 mg; Eq 25 mg; Eq 25 mg , Tablet, Oral)

Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate Gilead
200 mg; Eq 25 mg; Eq 25 mg , Tablet, Oral
More Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
ODEFSEY is indicated as a complete regimen for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg: as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL
Yes
******, ***** *** ***** *** ****. ****** ***** * **** ** ** ****** '*** *** '***. ***** *** ***** ***** * **** ** ** ******* '***, '***, '***, '***. ** ****** **** **** **** ****** ** *** ****. ********* ** *** ****** ** ******, ******** ****** ****** ** ****.
Odefsey Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
****** *** ********* *** ********* *** ********* *** ********* *** ********* ******* *** ********* *** ********* ******* *******
***** *** ********* *** ********* *** ********* *** ********* ******* ******* *** ********* *** ********* ******* *******
***** *** ********* *** ********* *** ********* *** ********* ******* ******* *** ********* *** ********* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* *** *, **** ******* **** ** *** **, ****
***** *** \ ********* *** *, **** ******* ********* ******** ** *** **, ****
***** *** \ ********* *** *, **** ******* **** ** *** **, ****
  1. *** **, **** : ****** ******** ****** ***** **'* **** ** ****** ** ******* '*** *** '***.
  2. *** *, **** : ***** ******** ****** ***** **'* **** ** ****** ** ******* '***, '***, '*** *** '***.
  3. *** **, **** : ***** ******** ****** ***** **'* **** ** ****** ** ******* '***, '***, '*** *** '***.
  4. *** *, **** : ****** ***** * **** ******* ****** ** ******* '*** *** '***.
  5. *** *, **** : ****** ***** * **** ******* ***** *** ***** ** ******* '***, '***, '*** *** '***.
  6. *** **, **** : ***** ****** ** ****** *** **** ** ************* ** ******* '*** *** '***
  7. *** **, **** : ****** ***** * **** ******* ******, ***** *** ***** ** ****** '*** '*** '*** *** '***
  8. *** *, **** : ****** ******* ********** **** ****** *** *****.
  9. *** **, **** : ****** ******* ********** **** *****.
  10. *** **, **** : ********* ** ********** ********* ***** ** ******'* *** ******, *** ******** *** ****** ** *** **, ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.